REVIEW
Published on 28 Sep 2026
Polystyrene-associated pulmonary fibrosis: a summary based on the available evidence and prospects
doi 10.3389/fimmu.2026.1953398
- 530 views
Articles
ORIGINAL RESEARCH
Published on 27 Aug 2026
NUFIP1 gain of function promotes fibrotic remodeling and reveals a ZNHIT3-linked metabolic vulnerability in idiopathic pulmonary fibrosis models
doi 10.3389/fimmu.2026.1909302
- 615 views
ORIGINAL RESEARCH
Published on 18 Aug 2026
Multi-omics integration identifies APOE as a metabolic regulator of macrophage-fibroblast crosstalk in idiopathic pulmonary fibrosis
doi 10.3389/fimmu.2026.1904638
- 2,739 views
ORIGINAL RESEARCH
Published on 26 May 2026
Single cell transcriptome signatures and cell-cell interactions associated with sarcoidosis in lung immune cell populations
doi 10.3389/fimmu.2026.1765314
- 2,758 views
ORIGINAL RESEARCH
Published on 11 May 2026
Lactylation-driven PDLIM1/PDAP1 axis remodels the inflammatory landscape of acute lung injury: mechanistic insights and precision intervention
doi 10.3389/fimmu.2026.1832309
- 1,764 views
- 1 citation
STUDY PROTOCOL
Published on 05 May 2026
Design of the MERCURION-IPF trial – intravenous immunoglobulin for the treatment of acute exacerbations of idiopathic pulmonary fibrosis
doi 10.3389/fimmu.2026.1777564
- 2,334 views
ORIGINAL RESEARCH
Published on 24 Apr 2026
Kangxianhuanji formula and its component rutin ameliorate acute exacerbation of idiopathic pulmonary fibrosis by targeting GLUT1 to suppress HIF-1α–mediated glycolysis
doi 10.3389/fimmu.2026.1783256
- 2,405 views
ORIGINAL RESEARCH
Published on 19 Mar 2026
Multi-omics integration and machine learning reveal gut-immune signatures in idiopathic pulmonary fibrosis: insights from bulk RNA-seq, single-cell profiles, spatial transcriptomics, and experimental validation
doi 10.3389/fimmu.2026.1730289
- 9,621 views
- 2 citations
REVIEW
Published on 11 Mar 2026
The immune dysregulation of fibrosis: insights into immune-fibrotic crosstalk and potential therapeutic targets
doi 10.3389/fimmu.2026.1770516
- 3,119 views
- 2 citations
ORIGINAL RESEARCH
Published on 18 Feb 2026
Nerandomilast attenuates idiopathic inflammatory myopathy-associated interstitial lung disease via inhibiting proliferation and differentiation of B cells
doi 10.3389/fimmu.2026.1771007
- 3,600 views
- 3 citations
CASE REPORT
Published on 17 Dec 2025
Lymphocyte dynamics as the central mediator in osimertinib-induced CD4+ T-cell depletion, fulminant cytomegalovirus pneumonitis, and progressive pulmonary fibrosis: a case report
doi 10.3389/fimmu.2025.1702074
- 2,565 views
- 1 citation
